Evidence map›Paper›PMID 18441095›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2008

EGF antagonizes TGF-beta-induced tropoelastin expression in lung fibroblasts via stabilization of Smad corepressor TGIF.

Shenghong Yang, Matthew A Nugent, Mikhail P Panchenko

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Matrix remodeling in chronic lung diseases.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Review
  4. Matrix Remodeling in Pulmonary Fibrosis and Emphysema.American journal of respiratory cell and molecular biology · 2016
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shenghong YangDepartment of Biochemistry, Boston University School of Medicine, 715 Albany St, Boston, Massachusetts 02118, USA.
Matthew A Nugent
Mikhail P Panchenko
Boston University · US

Funding

TROPOELASTIN SUBUNITS--STRUCTURE/FUNCTION RELATIONSHIPSP01HL046902 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI NUGENT, MATTHEW A · 1992 to 2006
$11.1M
Elastase Injury of Pulmonary Extracellular MatrixR01HL088572 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI NUGENT, MATTHEW A · 2008 to 2012
$2.0M
NHLBI NIH HHS P01 HL-046902NHLBI NIH HHS R01 HL-088572
6 · The paper itself

Abstract

We previously reported that neutrophil elastase (NE) downregulates transforming growth factor-beta (TGF-beta)-maintained tropoelastin mRNA levels in lung fibroblasts through transactivation of the epidermal growth factor (EGF) receptor (EGFR)/Mek/Erk pathway, which is dependent on the NE-initiated release of soluble EGFR ligands. In the present study, we investigated the mechanism by which EGF downregulates tropoelastin expression. We found that EGF downregulates tropoelastin expression through inhibition of TGF-beta signaling. We show that EGF does not prevent the TGF-beta-induced nuclear accumulation of Smad2/3; rather, EGF stabilizes the short-lived Smad transcriptional corepressor TG-interacting factor (TGIF) via EGFR/Mek/Erk-mediated phosphorylation of TGIF. Elevation of TGIF levels, either by TGIF overexpression or prevention of TGIF degradation, is sufficient to inhibit TGF-beta-induced tropoelastin expression. Moreover, TGIF is essential for EGF-mediated downregulation of tropoelastin expression, inasmuch as small interfering RNA knockdown of TGIF blocked EGF-induced downregulation of tropoelastin. Finally, we demonstrated that NE treatment, which releases EGF-like growth factors, causes stabilization of TGIF through the EGFR/Mek/Erk pathway. These results suggest that EGFR/Mek/Erk signaling specifically antagonizes the proelastogenic action of TGF-beta in lung fibroblasts by stabilizing the Smad transcriptional corepressor TGIF.

Indexed as

AnimalsDown-RegulationEpidermal Growth FactorErbB ReceptorsExtracellular Signal-Regulated MAP KinasesFibroblastsHomeodomain ProteinsHumansLeukocyte ElastaseLungMAP Kinase Kinase KinasesMAP Kinase Signaling SystemMicePhosphorylationRatsRats, Sprague-DawleyEGFR protein, humanEgfr protein, ratEpidermal Growth FactorErbB ReceptorsExtracellular Signal-Regulated MAP KinasesHomeodomain ProteinsLeukocyte ElastaseMAP Kinase Kinase KinasesRepressor ProteinsRNA, Small InterferingSmad ProteinsTGIF1 protein, humanTgif1 protein, mouseTransforming Growth Factor betaTropoelastin

Identifiers

PMID18441095
PMCPMC2494790
OpenAlexW2120334944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.